腎機能障害を有する非弁膜症性心房細動患者における抗凝固療法中の有害臨床イベント発症

• 資料種別: 記事
• タイトル: 腎機能障害を有する非弁膜症性心房細動患者における抗凝固療法中の有害臨床イベント発症
• 著者標目: 中島 一夫; 仲 元司; 西山 修; 高濱 充貴; 西森 栄太
• 出版年月日等: 2021
• 出版年（W3CDTF）: 2021
• タイトル（掲載誌）: 脳卒中
• 巻号年月日等（掲載誌）: 43 4
• 掲載巻: 43
• 掲載号: 4
• 掲載ページ: 313-319
• 掲載年月日（W3CDTF）: 2021
• ISSN（掲載誌）: 09120726
• ISSN-L（掲載誌）: 09120726
• 出版事項（掲載誌）: The Japan Stroke Society
• 本文の言語コード: ja
• 件名標目: nonvalvular atrial fibrillation; renal dysfunction; warfarin; DOAC; adverse clinical event
• 対象利用者: 一般
• DOI: 10.3995/jstroke.10838; https://doi.org/10.3995/jstroke.10838
• 関連情報（URI）: https://www.jstage.jst.go.jp/article/jstroke/43/4/43_10838/_pdf; https://search.jamas.or.jp/link/ui/2022036144
• 参照: Net Clinical Benefit of Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation: A Subgroup Analysis of J-ROCKET AF; https://cir.nii.ac.jp/crid/1360002216047050752; Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients; https://cir.nii.ac.jp/crid/1360011146269913216; Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry; https://cir.nii.ac.jp/crid/1360567184519147776; A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy; https://cir.nii.ac.jp/crid/1360574095378481664; A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation; https://cir.nii.ac.jp/crid/1360855569287570432; Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease; https://cir.nii.ac.jp/crid/1361418521204811008; Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation; https://cir.nii.ac.jp/crid/1362262943549378944; Meta-analysis of safety and efficacy for direct oral anticoagulation treatment of non-valvular atrial fibrillation in relation to renal function; https://cir.nii.ac.jp/crid/1362262943719397504; Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care; https://cir.nii.ac.jp/crid/1362544419199070976; A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation; https://cir.nii.ac.jp/crid/1362544419963342208; Validation of Clinical Classification Schemes for Predicting Stroke; https://cir.nii.ac.jp/crid/1362825895416990464; Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation; https://cir.nii.ac.jp/crid/1363670320555687040; The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation; https://cir.nii.ac.jp/crid/1363951795961195648; Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry); https://cir.nii.ac.jp/crid/1363951795980146944; Stroke prevention in atrial fibrillation: An Asian perspective; https://cir.nii.ac.jp/crid/1364233270052172672; Guideline for pharmacotherapy of atrial fibrillation (JCS 2013); https://cir.nii.ac.jp/crid/1390282680084238720
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• 提供元機関・データベース: Japan Link Center; https://japanlinkcenter.org/top; Crossref; https://www.crossref.org; CiNii Articles
• NII論文ID: 130008067584

• 要約等: <p><b>要旨</b>：【目的および方法】腎機能障害（推定糸球体濾過量 <60 ml/min/1.73 m2）を有する非弁膜症性心房細動（NVAF）患者中，ワルファリン（Wa）投与166例（79±8歳）および直接阻害型経口抗凝固薬（DOAC）投与196例（80±10 歳）の有害臨床イベント発症率を...